Malvern-based Endo has approved $3.5 million in retention bonuses for its key executives as it works toward a merger with ...

The notice states that Mallinckrodt failed to clean up contaminated portions of the site to health and safety standards.

Five presentations highlight TERLIVAZ research in adults with HRS with rapid reduction in kidney function,1 also known as HRS-AKI<sup ...

Endo Inc. approved more than $3.5 million in retention bonuses for key executives, and that figure could grow, as it works to ...

DUBLIN, April 10, 2025 /PRNewswire/ -- Mallinckrodt plc, a global specialty pharmaceutical company, today announced that it will report its first quarter 2025 financial results on Tuesday ...

India’s exporters are bracing for President Donald Trump’s tariffs. Some are confident that whatever is announced on Wednesday will not hurt them; others are genuinely uncertain how to manage if they ...

Ireland’s Mallinckrodt will buy U.S. drugmaker Endo in a cash-and-stock deal valued at $6.7 billion. The companies said Thursday that Endo shareholders will receive a total of $80 million in cash and ...

(RTTNews) - Specialty pharmaceutical companies Mallinckrodt plc and Endo, Inc. announced Thursday that they have entered into a definitive agreement to combine in a stock and cash transaction.

MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Endo (OTCQX: NDOI) for possible breaches of fiduciary duty and other violations of law in its transaction with Mallinckrodt. Click here ...

Endo and Mallinckrodt, two drugmakers seeking to recover from opioid lawsuits and bankruptcies, are betting a combination will help. Investors took a dim view Thursday. Shares of Endo fell more ...